CS logo
small CS logo
Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie

Linz, Austria
University hospital in Linz
Krankenhausstraße 9, 4020 Linz

About Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Arbeitsgemeinschaft medikamentoese Tumortherapie
3
University Hospital Muenster
2
Total Rows: 2

Clinical Trials at Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie


During the past decade, Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years2200111100000000Started TrialsCompleted Trails20172018201920200123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Registry on Hypomethylating Agents in Myeloid Neoplasms
2009-02-09
2021-12-01
Active, not recruiting
1,500
Combination of Obinutuzumab and Venetoclax in Relapsed or Refractory DLBCL
2017-01-04
2021-10-19
Completed
22
Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents
2017-08-03
2024-08-01
Recruiting
650
International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
2019-08-23
2027-11-22
Recruiting
683
Austrian Myeloid Registry
2020-07-13
2030-04-01
Recruiting
3,000

Rows per page:

1–5 of 5

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie" #1 collaborator was "Deutsche Krebshilfe e.V., Bonn (Germany)" with 2 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsArbeitsgemeinschaftmedikamentoeseTumortherapie: 3ArbeitsgemeinschaftmedikamentoeseTumortherapie: 3University Hospital Muenster: 2University Hospital Muenster: 2

Created with Highcharts 11.1.0Top CollaboratorsDeutsche Krebshilfee.V., Bonn (Germany):2Deutsche Krebshilfee.V., Bonn (Germany):2Roche Pharma AG: 1Roche Pharma AG: 1

Clinical Trials Conditions at Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie


According to Clinical.Site data, the most researched conditions in "Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie" are "Acute Myeloid Leukemia" (1 trials), "Chronic Myelomonocytic Leukemia" (1 trials), "Lymphoblastic Lymphoma, Childhood" (1 trials), "Lymphoma, Large B-Cell, Diffuse" (1 trials) and "Mature B-cell Non-Hodgkin Lymphoma" (1 trials). Many other conditions were trialed in "Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie" in a lesser frequency.

Clinical Trials Intervention Types at Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie


Most popular intervention types in "Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie" are "Drug" (3 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Cyclophosphamide" (2 trials), "Cytarabine" (2 trials), "Dexamethasone" (2 trials), "Ifosfamide" (2 trials) and "Methotrexate" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie


The vast majority of trials in "Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie" are 5 trials for "All" genders.

Clinical Trials Status at Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie


Currently, there are NaN active trials in "Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 2Phase 3: 2Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusRecruiting: 3Recruiting: 3Active, not recruiting: 1Active, not recruiting: 1Completed: 1Completed: 1